GSE161825
RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)
We performed RNA-seq analysis of human gastric cancer stem cell treated with or without Tipranavir to elucidate the effect of Tipranavir on GCSCs, and find Tipranavir's potential targets in GCSCs. Overall design: Fresh isolated, primary tumor-derived GCSC cells were treated with or without Tipranavir for 24 h, and then were collected for TRIzol lysed for RNA extraction. 6 RNAseq samples across 2 conditions:Control (n=3) and Tipranavir (n=3)